Atıf İçin Kopyala
Sagara Y., Freedman R. A., Wong S. M., Aydogan F., Nguyen A., Barry W. T., ...Daha Fazla
BREAST CANCER RESEARCH AND TREATMENT, cilt.166, sa.2, ss.583-592, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
166
Sayı:
2
-
Basım Tarihi:
2017
-
Doi Numarası:
10.1007/s10549-017-4436-9
-
Dergi Adı:
BREAST CANCER RESEARCH AND TREATMENT
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.583-592
-
İstanbul Üniversitesi Adresli:
Hayır
Özet
Breast-conserving surgery (BCS) followed by radiotherapy (RT) with or without endocrine therapy (ET) is a standard treatment option for ductal carcinoma in situ (DCIS). We sought to investigate national patterns in the use of adjuvant therapy after BCS for hormone receptor (HR)-positive DCIS over time.